Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The <scp>VERTIS FACTORIAL</scp> randomized trial - Concepedia

Concepedia

Publication | Open Access

Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The <scp>VERTIS FACTORIAL</scp> randomized trial

DOI Full Paper Access

158

Citations

23

References

2017

Year

Richard E. Pratley, Roy Eldor, Annaswamy Raji, Gregory T. Golm, Susan Huyck, Yanping Qiu, Sheila Sunga, Jeremy Johnson, Steven G. Terra, James P. Mancuso,

Diabetes Obesity and Metabolism

Abstract

In patients with uncontrolled type 2 diabetes while using metformin, co-administration of ertugliflozin and sitagliptin provided more effective glycaemic control through 52 weeks compared with the individual agents.

References

	Year	Citations

Page 1